Anti-IgE monoclonal antibody (omalizumab) treatment increases blood glucose levels in severe persistent allergic asthma patients with type 2 diabetes


Yalcin A. D., Cilli A., Gorczynski R., Bisgin A., Strauss L.

World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, Italy, 22 - 26 June 2013, vol.68, pp.364

  • Publication Type: Conference Paper / Summary Text
  • Volume: 68
  • City: Milan
  • Country: Italy
  • Page Numbers: pp.364
  • Akdeniz University Affiliated: Yes